CompletedPhase 4

Locally Delivered 1% Metformin Gel in Peri-implantitis

46 participantsStarted 2015-03-15

Plain-language summary

This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel with manual debridement while the other half will receive a placebo with manual debridement.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type 2 diabetes mellitus patients. * Patients with peri-implantitis Exclusion Criteria: * History of any other systemic diseases * Cigarette smokers * Smokeless tobacco users * Patients who underwent scaling in the last 1 year * Patients who took antibiotics in tje past 6 months

What they're measuring

Marginal bone loss

Timeframe: 6 months

Peri-implant prpbing depth

Timeframe: 6 months

Trial details

NCT IDNCT03312582

SponsorKing Saud University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-08-14

View on ClinicalTrials.gov More Peri-Implantitis trials